fluphenazine depot has been researched along with dantrolene in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adler, S; Coyle, J; Granato, JE; Karim, AH; Krumholz, A; Ringel, A; Stern, BJ | 1 |
Cape, G | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
3 other study(ies) available for fluphenazine depot and dantrolene
Article | Year |
---|---|
Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine.
Topics: Adult; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Drug Therapy, Combination; Fluphenazine; Humans; Male; Schizophrenia | 1983 |
Neuroleptic malignant syndrome--a cautionary tale and a surprising outcome.
Topics: Activities of Daily Living; Adaptation, Psychological; Adult; Antisocial Personality Disorder; Combined Modality Therapy; Critical Care; Dantrolene; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Follow-Up Studies; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Schizoid Personality Disorder; Sick Role; Social Environment; Substance Withdrawal Syndrome | 1994 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |